CTKB vs SNY
Cytek Biosciences Inc (CTKB) versus SNY (SNY) — a side-by-side from cached financials, not a winner call.
Cytek Biosciences Inc (CTKB) is a medical devices company listed on US.
SNY (SNY) common stock.
Latest reported CTKB revenue for 2026-06-30 was $92.3M. Net income was -$31.0M. CTKB currently screens at market cap $421.8M.
SNY does not have a complete income-statement cache yet.
CTKB currently screens at market cap $421.8M. SNY currently screens at market cap $0.
Not investment advice. Open the CTKB and SNY stock pages for the full models.
Not investment advice.